Array BioPharma Licenses Gastric Cancer Compound To Singapore's ASLAN; ASLAN Will Bring To POC And Find Partner
This article was originally published in The Pink Sheet Daily
Executive Summary
Partnership enables Array to focus its resources on two compounds that are furthest in development and gain expertise in the Asian market.